FLUID COMPONENT ANALYSIS SYSTEM AND METHOD FOR GLUCOSE MONITORING AND CONTROL
First Claim
1. A patient treatment and analysis system, comprising:
- a body fluid analyzer configured to;
measure a concentration of an analyte in a bodily fluid; and
access an analyte history database and store the measured concentration of the analyte in the analyte history database; and
a treatment dosing system in communication with the body fluid analyzer, the treatment dosing system comprising;
a source of a treatment substance; and
a treatment dosing algorithm stored in a computer memory;
wherein the treatment dosing system is configured to;
use the treatment dosing algorithm to calculate an estimated treatment sensitivity for the patient by accessing the analyte history database and a dosage history database and comparing portions of the analyte history database to portions of the dosage history database;
use the treatment dosing algorithm to calculate a recommended treatment dosage for the patient based at least in part on the estimated treatment sensitivity;
administer a dose of the treatment substance to the patient; and
access a dosage history database and store a record of the administered dose therein.
4 Assignments
0 Petitions
Accused Products
Abstract
Disclosed are methods and apparatuses for determining analyte concentration in a sample such as bodily fluid. Systems and methods disclosed herein can also include a treatment dosing system to infuse or inject a treatment dose (e.g. insulin, dextrose, etc.) and provide glycemic control. The dose of the treatment drug may be based on the patient'"'"'s calculated sensitivity to treatment dosing, for example. The dose of the treatment drug may be based on the concentration of the analyte or the average value for the concentration of the analyte and/or the rate of change of the value of the concentration of the analyte. Delivery of the treatment drug can be cut off if the determined analyte concentration indicates that continued delivery would be harmful to the patient.
-
Citations
21 Claims
-
1. A patient treatment and analysis system, comprising:
-
a body fluid analyzer configured to; measure a concentration of an analyte in a bodily fluid; and access an analyte history database and store the measured concentration of the analyte in the analyte history database; and a treatment dosing system in communication with the body fluid analyzer, the treatment dosing system comprising; a source of a treatment substance; and a treatment dosing algorithm stored in a computer memory; wherein the treatment dosing system is configured to; use the treatment dosing algorithm to calculate an estimated treatment sensitivity for the patient by accessing the analyte history database and a dosage history database and comparing portions of the analyte history database to portions of the dosage history database; use the treatment dosing algorithm to calculate a recommended treatment dosage for the patient based at least in part on the estimated treatment sensitivity; administer a dose of the treatment substance to the patient; and access a dosage history database and store a record of the administered dose therein. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
-
-
10. A patient monitoring and dosing system, comprising:
-
a body fluid analyzer configured to measure a concentration of an analyte in a sample of bodily fluid from a patient; and a treatment dosing system in communication with the body fluid analyzer, said treatment dosing system comprising a treatment dosing algorithm stored in a computer memory, the treatment dosing algorithm being configured to automatically calculate; an estimated treatment sensitivity for the patient based at least in part on the measured concentration of the analyte; and a recommended treatment dosage for the patient, wherein the automatic calculation of the recommended treatment dosage is based at least in part on the estimated treatment sensitivity. - View Dependent Claims (11, 12, 13, 14, 15, 16, 17, 18, 19, 20)
-
-
21-100. -100. (canceled)
Specification